Drugs / R926112
last change Sep 2005 re-read 2 minutes ago

R926112

Developed for
seasonal allergic rhinitis
Investigated by
Rigel Pharmaceuticals

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00115089 Jul → Sep 2005 seasonal allergic rhinitis Rigel Pharmaceuticals Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as R926112 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00115089